Sign up to save your podcasts
Or
Share The Global Debate on Obesity Management Medicines
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
The Global Debate on Obesity Management Medicines
Weight loss drugs are increasingly dominating headlines, but should they instead be understood as obesity management medicines?
This episode of Connecting Citizens to Science explores the growing global debate surrounding GLP-1 medicines, obesity as a complex chronic disease, and the wider implications for health systems, equity and access across different global contexts. The discussion examines the benefits these medicines may offer beyond weight reduction, alongside concerns around affordability, regulation, stigma and widening inequalities between those who can access treatment safely and those who cannot.
In this episode:
Dr Fatima Cody Stanford - Associate Professor of Medicine and Pediatrics at Harvard Medical School and Massachusetts General Hospital.
Dr Fatima is an obesity medicine physician-scientist whose work focuses on obesity as a chronic disease, cardiometabolic health and improving equitable access to evidence-based care. Alongside her clinical and research work, she contributes to national and international policy discussions through roles including the Lancet Commission on Obesity and the 2025 US Dietary Guidelines Advisory Committee, while also mentoring underrepresented researchers through NIH-funded programmes.
Dr Swarup K. Chakrabarti - Consulting Director at Biotech Consulting Services.
Dr Swarup is a biomedical scientist and translational research professional with experience spanning academia, biotechnology and interdisciplinary human health research across India and the United States. His work has explored inflammation, metabolic disease and the wider societal impact of GLP-1 therapies, including questions around long-term health outcomes and access in lower-resource settings.
- The Impact of Weight Loss Drugs on Health and Society in India | Biores Scientia
Want to hear more podcasts like this?
Follow Connecting Citizens to Science on your preferred podcast platform or YouTube to hear more about current research and debates within global health and development.
The podcast cuts across disciplines, including health systems strengthening, gender and intersectionality, tropical diseases (NTDs, TB, Malaria), maternal and child healthcare (antenatal and postnatal care), mental health and wellbeing, vector-borne diseases, climate change and co-production approaches.
If you would like your project or programme to feature in an episode or miniseries, get in touch with the producers of Connecting Citizens to Science, the SCL Agency.
View all episodes
By The SCL AgencyWeight loss drugs are increasingly dominating headlines, but should they instead be understood as obesity management medicines?
This episode of Connecting Citizens to Science explores the growing global debate surrounding GLP-1 medicines, obesity as a complex chronic disease, and the wider implications for health systems, equity and access across different global contexts. The discussion examines the benefits these medicines may offer beyond weight reduction, alongside concerns around affordability, regulation, stigma and widening inequalities between those who can access treatment safely and those who cannot.
In this episode:
Dr Fatima Cody Stanford - Associate Professor of Medicine and Pediatrics at Harvard Medical School and Massachusetts General Hospital.
Dr Fatima is an obesity medicine physician-scientist whose work focuses on obesity as a chronic disease, cardiometabolic health and improving equitable access to evidence-based care. Alongside her clinical and research work, she contributes to national and international policy discussions through roles including the Lancet Commission on Obesity and the 2025 US Dietary Guidelines Advisory Committee, while also mentoring underrepresented researchers through NIH-funded programmes.
Dr Swarup K. Chakrabarti - Consulting Director at Biotech Consulting Services.
Dr Swarup is a biomedical scientist and translational research professional with experience spanning academia, biotechnology and interdisciplinary human health research across India and the United States. His work has explored inflammation, metabolic disease and the wider societal impact of GLP-1 therapies, including questions around long-term health outcomes and access in lower-resource settings.
- The Impact of Weight Loss Drugs on Health and Society in India | Biores Scientia
Want to hear more podcasts like this?
Follow Connecting Citizens to Science on your preferred podcast platform or YouTube to hear more about current research and debates within global health and development.
The podcast cuts across disciplines, including health systems strengthening, gender and intersectionality, tropical diseases (NTDs, TB, Malaria), maternal and child healthcare (antenatal and postnatal care), mental health and wellbeing, vector-borne diseases, climate change and co-production approaches.
If you would like your project or programme to feature in an episode or miniseries, get in touch with the producers of Connecting Citizens to Science, the SCL Agency.